Mavupharma's Series A Round

Mavupharma raised a round of funding on November 29, 2017.

Mavupharma is a drug discovery and development company that is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.…

Articles about Mavupharma's Series A Round: